Cargando…
Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma (cHCC/CCA) represents a rare type of primary liver cancer with a very limited prognosis. Although just recently genomic studies have contributed to a better understanding of the disease's genetic landscape, therapeutic options, especially for advanced-...
Autores principales: | Loosen, Sven H., Gaisa, Nadine T., Schmeding, Maximilian, Heining, Christoph, Uhrig, Sebastian, Wirtz, Theresa H., Kalverkamp, Sebastian, Spillner, Jan, Tacke, Frank, Stenzinger, Albrecht, Glimm, Hanno, Fröhling, Stefan, Trautwein, Christian, Roderburg, Christoph, Longerich, Thomas, Neumann, Ulf Peter, Luedde, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772835/ https://www.ncbi.nlm.nih.gov/pubmed/33442346 http://dx.doi.org/10.1159/000511034 |
Ejemplares similares
-
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2016) -
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2017) -
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
por: Roderburg, Christoph, et al.
Publicado: (2021) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019) -
Serum Levels of miR-143 Predict Survival in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)